Presenting @ASH_hematology our novel approach to multi-source, multi-omic data-driven target antigen discovery – with a first application to CAR-T for multiple myeloma with @j_eyquem's lab at UCSF: https://t.co/Jp567lRKd3
We're thrilled to be participating and presenting research at the 64th American Society of Hematology meeting! @ASH_hematology
Learn more about this annual meeting and exposition running December 10th through December 13th.
https://t.co/gWnUsXst48
Epigene Labs receives the French Concours d'Innovation i-Nov prize to accelerate the development of its multi-omic, multi-source, multi-cancer platform to bring better treatments to cancer patients faster #data#drugdiscovery#biomarker#oncology https://t.co/QgWye1WtCs
#MEET2WIN Convention Partnering Européenne en Oncologie c’est aussi la mise en avant de projets innovants !
Ainsi la session QUICK PITCH mettra en lumière 10 projets de R&D prometteurs !
Objectif : accélérer les moyens de lutte contre le cancer 🤝
https://t.co/ZvJyCDlNID
🗣️ As @akpelinordor, co-founder and CEO of @epigenelabs, stated: “[…] We look forward to continuing our collaboration with Servier to rapidly get cancer patients the best treatments”.
Check out more 👉 https://t.co/sqKgVfONSX
🗣️ Céline Triquel, Open Innovation Project Manager at Servier, concluded: “Many values were revealed throughout this project: collaborative work methods, agility, courage, and perseverance for the benefits of innovation for patients”
More 👉 https://t.co/sqKgVfONSX
@epigenelabs
🗣️ Hear from Céline Lefebvre, Head of Computational Medicine at Servier, who shares a few words about the new app📱.
Check out more 👉 https://t.co/sqKgVfONSX
@epigenelabs
We are pleased to announce that Servier and @epigenelabs have developed a #webapp 📱 to prioritize #oncology indications, drastically reducing the time spent finding the best therapeutic strategy for #cancer#patients.
The app will be operational 🗓️ early first quarter of 2022.
@Servier Thank you. We are pleased to partner with @Servier to prioritize #oncology indications, which will help physicians find the best therapeutic strategies for #cancer#patients.
La seconde série d'entreprises sélectionnées pour recevoir des financements de la @EUeic est officielle.
🙌 Parmi les startups sélectionnées, @epigenelabs, #LiliAI et @ThrustMe_ , toutes trois ayant été incubées chez @Agoranov_innov.
+ d'info 👇 https://t.co/BszsXU77tK
Epigene Labs is proud to be among the recipients of the @EUeic#EICAccelerator's largest-ever funding round. We look forward to accelerating our mCUBE platform to leverage molecular and clinical data to accelerate precision oncology #precisiononcology https://t.co/u8Y6YQwga3
The latest updates from the largest #eicAccelerator round of funding ever! 🚀
👏 99 companies
💶 Total recommended budget of €627M
👩💼 19% of companies with a female CEO
Learn more about these newly #EUeic backed companies ➡️ https://t.co/qSxRxQ4tQG
"We really need to find a solution to let these datasets help as many patients as possible and not just be used once to publish a scientific paper" @akpelinordor@TMJHealth https://t.co/uTH6EfS9sJ
@epigenelabs has put AI to work to cure cancer, transforming genomic data into predictions used by laboratories to develop new cancer treatments. On the French national week against cancer, we wanted to congratulate @akpelinordor & Arthur de Garidel for their work👏#faceaucancer
Arthur de Garidel, Co-founder & COO @epigenelabs, was recently sharing his professional experience at the intersection of data and biotech with graduate students @ESCP_MsM@ESCP_bs https://t.co/w1BAU93CBZ
Nous avons eu la chance d'écouter Arthur de Garidel nous décrire la révolution de l'utilisation de l'IA dans le domaine de la santé. "Que peut-elle faire ? Dans quels domaines l'IA est-elle utilisée ?" Sont autant de questions auxquelles Arthur à répondu.
Merci beaucoup Arthur !
Honored to be nominated by @GalienFdn & @businessfrance for the Prix Galien Medstartup 2020 for our collaboration with @j_eyquem's team @UCSF on genomic data-driven target discovery https://t.co/ZjLebwNnI5
We are hiring talented engineers to put our machine learning, natural language processing, and advance statistics pipelines in production, with a unique opportunity to accelerate drug discovery for cancer patients: https://t.co/0k97dNq8gs
Grateful to be on Station F's 2020 Top 30 list - developing our early-stage company as part of such a vibrant community has been blast! @joinstationf#TOP30 https://t.co/mxMmHs5zhl
Proud to get in the fight against ovarian cancer alongside @institut_curie! Learn more about our partnership centered on augmented intelligence approaches for genomic data-driven translational medicine here: https://t.co/D1yx2dhOfX
#Innovation 🌟 Nous sommes très fiers de nos chercheurs, dont l’expertise en #oncologie a permis l’émergence d’un nouveau partenariat #IA 🤝 avec @epigenelabs : des progrès majeurs dans la prise en charge du #cancer de l’ovaire ! @akpelinordor. Focus ▶️ https://t.co/1bOp5GemQo